Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?

标题
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
作者
关键词
-
出版物
DRUG DISCOVERY TODAY
Volume 15, Issue 3-4, Pages 88-97
出版商
Elsevier BV
发表日期
2009-12-04
DOI
10.1016/j.drudis.2009.11.006

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started